Press release from Business Wire India
Source: MakroCare
Thursday, September 16, 2010 03:32 PM IST (10:02 AM GMT)
Editors: General: Consumer interest; Business: Advertising, PR & marketing, Business services, Healthcare, biotechnology & pharmaceutical; Healthcare
--------------------------------------------------
MakroCare Opens Switzerland Presence
Hyderabad, Andhra Pradesh, India, Thursday, September 16, 2010 -- (Business Wire India) -- Life Sciences has always been a top priority for Switzerland. This focus of the country led to good growth of pharma, biotech, nutrition and medical devices in the country over the decades. To support local firms in expanding and managing global projects, MakroCare announced the opening of a new international office in Basel. This office, along with it's presence in other parts of Europe will offer local support to European firms who want to expand to other regions and vice versa. MakroCare is a multidisciplinary knowledge and technology driven global firm that provides clinical, medical, informatics, and consulting services to pharmaceutical, biotechnology, medical devices, and food/nutrition industries.
MakroCare has well integrated four main focused divisions - CRO, Consulting, Informatics and SMO. Through these divisions, it offers project management, regulatory affairs, risk management, site selection, patient recruitment, trial management (P II/III and late phase), clinical monitoring, biometrics (cdm, edc, biostat, SAS, medical writing), audits, pharmacovigilance, informatics (products, services), call center and medical affairs. The company has other offices in USA and Asia.
CONTACT DETAILS
Shah Javid, Communications Team, MakroCare, shah.javid@makrogrp.com
KEYWORDS
CONSUMER, MARKETING, BUSINESS SERVICES, HEALTHCARE, HEALTHCARE
If you wish to change your Business Wire India selection please click on this link http://www.businesswireindia.com/media/news.asp and use your personal username and password to login.
Submit your press release at http://www.businesswireindia.com
No comments:
Post a Comment